Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Chitosan-based Hemostatic Gauze Market Research Report 2026
Global Chitosan-based Hemostatic Gauze Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 115 Pages
Report ld: 5601389
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Chitosan-based Hemostatic Gauze market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Chitosan-based Hemostatic Gauze competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
The North American market for Chitosan-based Hemostatic Gauze is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Chitosan-based Hemostatic Gauze is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Chitosan-based Hemostatic Gauze include Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Chitosan-based Hemostatic Gauze market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chitosan-based Hemostatic Gauze. The Chitosan-based Hemostatic Gauze market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Chitosan-based Hemostatic Gauze market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chitosan-based Hemostatic Gauze manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Anscare
- Tricol Biomedical
- Advamedica
- Hemoflex
- Mermaid Medical
- BioPharm Med
- MedTrade Products
- Shijiazhuang Yishengtang Medical Product
- Biotemed
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Z-shaped Folded Hemostatic Gauze
- Non-folded Hemostatic Gauze
Segment by Application
- Surgery
- First Aid
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Chitosan-based Hemostatic Gauze manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Chitosan-based Hemostatic Gauze sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Chitosan-based Hemostatic Gauze Market Overview
1.1 Product Definition
1.2 Chitosan-based Hemostatic Gauze by Type
1.2.1 Global Chitosan-based Hemostatic Gauze Market Value by Type: 2025 vs 2032
1.2.2 Z-shaped Folded Hemostatic Gauze
1.2.3 Non-folded Hemostatic Gauze
1.3 Chitosan-based Hemostatic Gauze by Application
1.3.1 Global Chitosan-based Hemostatic Gauze Market Value by Application: 2025 vs 2032
1.3.2 Surgery
1.3.3 First Aid
1.4 Global Chitosan-based Hemostatic Gauze Market Size Estimates and Forecasts
1.4.1 Global Chitosan-based Hemostatic Gauze Revenue 2021–2032
1.4.2 Global Chitosan-based Hemostatic Gauze Sales 2021–2032
1.4.3 Global Chitosan-based Hemostatic Gauze Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Chitosan-based Hemostatic Gauze Market Competition by Manufacturers
2.1 Global Chitosan-based Hemostatic Gauze Sales Market Share by Manufacturers (2021–2026)
2.2 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Chitosan-based Hemostatic Gauze Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Chitosan-based Hemostatic Gauze, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Product Types and Applications
2.7 Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Date of Entry into the Industry
2.8 Global Chitosan-based Hemostatic Gauze Market Competitive Situation and Trends
2.8.1 Global Chitosan-based Hemostatic Gauze Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Chitosan-based Hemostatic Gauze Players Market Share by Revenue
2.8.3 Global Chitosan-based Hemostatic Gauze Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Chitosan-based Hemostatic Gauze Market Scenario by Region
3.1 Global Chitosan-based Hemostatic Gauze Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Chitosan-based Hemostatic Gauze Sales by Region: 2021–2032
3.2.1 Global Chitosan-based Hemostatic Gauze Sales by Region: 2021–2026
3.2.2 Global Chitosan-based Hemostatic Gauze Sales by Region: 2027–2032
3.3 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2021–2032
3.3.1 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2021–2026
3.3.2 Global Chitosan-based Hemostatic Gauze Revenue by Region: 2027–2032
3.4 North America Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
3.4.1 North America Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)
3.4.3 North America Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
3.5.1 Europe Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)
3.5.3 Europe Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chitosan-based Hemostatic Gauze Market Facts & Figures by Region
3.6.1 Asia Pacific Chitosan-based Hemostatic Gauze Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Chitosan-based Hemostatic Gauze Sales by Region (2021–2032)
3.6.3 Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
3.7.1 Latin America Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)
3.7.3 Latin America Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chitosan-based Hemostatic Gauze Market Facts & Figures by Country
3.8.1 Middle East and Africa Chitosan-based Hemostatic Gauze Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (2021–2032)
3.8.3 Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021–2032)
4.1.1 Global Chitosan-based Hemostatic Gauze Sales by Type (2021–2026)
4.1.2 Global Chitosan-based Hemostatic Gauze Sales by Type (2027–2032)
4.1.3 Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021–2032)
4.2 Global Chitosan-based Hemostatic Gauze Revenue by Type (2021–2032)
4.2.1 Global Chitosan-based Hemostatic Gauze Revenue by Type (2021–2026)
4.2.2 Global Chitosan-based Hemostatic Gauze Revenue by Type (2027–2032)
4.2.3 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2021–2032)
4.3 Global Chitosan-based Hemostatic Gauze Price by Type (2021–2032)
5 Segment by Application
5.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021–2032)
5.1.1 Global Chitosan-based Hemostatic Gauze Sales by Application (2021–2026)
5.1.2 Global Chitosan-based Hemostatic Gauze Sales by Application (2027–2032)
5.1.3 Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021–2032)
5.2 Global Chitosan-based Hemostatic Gauze Revenue by Application (2021–2032)
5.2.1 Global Chitosan-based Hemostatic Gauze Revenue by Application (2021–2026)
5.2.2 Global Chitosan-based Hemostatic Gauze Revenue by Application (2027–2032)
5.2.3 Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2021–2032)
5.3 Global Chitosan-based Hemostatic Gauze Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Anscare
6.1.1 Anscare Company Information
6.1.2 Anscare Description and Business Overview
6.1.3 Anscare Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Anscare Chitosan-based Hemostatic Gauze Product Portfolio
6.1.5 Anscare Recent Developments/Updates
6.2 Tricol Biomedical
6.2.1 Tricol Biomedical Company Information
6.2.2 Tricol Biomedical Description and Business Overview
6.2.3 Tricol Biomedical Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Tricol Biomedical Chitosan-based Hemostatic Gauze Product Portfolio
6.2.5 Tricol Biomedical Recent Developments/Updates
6.3 Advamedica
6.3.1 Advamedica Company Information
6.3.2 Advamedica Description and Business Overview
6.3.3 Advamedica Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Advamedica Chitosan-based Hemostatic Gauze Product Portfolio
6.3.5 Advamedica Recent Developments/Updates
6.4 Hemoflex
6.4.1 Hemoflex Company Information
6.4.2 Hemoflex Description and Business Overview
6.4.3 Hemoflex Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hemoflex Chitosan-based Hemostatic Gauze Product Portfolio
6.4.5 Hemoflex Recent Developments/Updates
6.5 Mermaid Medical
6.5.1 Mermaid Medical Company Information
6.5.2 Mermaid Medical Description and Business Overview
6.5.3 Mermaid Medical Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Mermaid Medical Chitosan-based Hemostatic Gauze Product Portfolio
6.5.5 Mermaid Medical Recent Developments/Updates
6.6 BioPharm Med
6.6.1 BioPharm Med Company Information
6.6.2 BioPharm Med Description and Business Overview
6.6.3 BioPharm Med Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BioPharm Med Chitosan-based Hemostatic Gauze Product Portfolio
6.6.5 BioPharm Med Recent Developments/Updates
6.7 MedTrade Products
6.7.1 MedTrade Products Company Information
6.7.2 MedTrade Products Description and Business Overview
6.7.3 MedTrade Products Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 MedTrade Products Chitosan-based Hemostatic Gauze Product Portfolio
6.7.5 MedTrade Products Recent Developments/Updates
6.8 Shijiazhuang Yishengtang Medical Product
6.8.1 Shijiazhuang Yishengtang Medical Product Company Information
6.8.2 Shijiazhuang Yishengtang Medical Product Description and Business Overview
6.8.3 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product Portfolio
6.8.5 Shijiazhuang Yishengtang Medical Product Recent Developments/Updates
6.9 Biotemed
6.9.1 Biotemed Company Information
6.9.2 Biotemed Description and Business Overview
6.9.3 Biotemed Chitosan-based Hemostatic Gauze Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Biotemed Chitosan-based Hemostatic Gauze Product Portfolio
6.9.5 Biotemed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chitosan-based Hemostatic Gauze Industry Chain Analysis
7.2 Chitosan-based Hemostatic Gauze Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chitosan-based Hemostatic Gauze Production Mode & Process Analysis
7.4 Chitosan-based Hemostatic Gauze Sales and Marketing
7.4.1 Chitosan-based Hemostatic Gauze Sales Channels
7.4.2 Chitosan-based Hemostatic Gauze Distributors
7.5 Chitosan-based Hemostatic Gauze Customer Analysis
8 Chitosan-based Hemostatic Gauze Market Dynamics
8.1 Chitosan-based Hemostatic Gauze Industry Trends
8.2 Chitosan-based Hemostatic Gauze Market Drivers
8.3 Chitosan-based Hemostatic Gauze Market Challenges
8.4 Chitosan-based Hemostatic Gauze Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Chitosan-based Hemostatic Gauze Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Chitosan-based Hemostatic Gauze Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Chitosan-based Hemostatic Gauze Market Competitive Situation by Manufacturers in 2025
Table 4. Global Chitosan-based Hemostatic Gauze Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Chitosan-based Hemostatic Gauze Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Chitosan-based Hemostatic Gauze Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Chitosan-based Hemostatic Gauze Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Chitosan-based Hemostatic Gauze, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Product Types and Applications
Table 12. Global Key Manufacturers of Chitosan-based Hemostatic Gauze, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chitosan-based Hemostatic Gauze Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chitosan-based Hemostatic Gauze Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chitosan-based Hemostatic Gauze Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Chitosan-based Hemostatic Gauze Sales by Region (Units), 2021–2026
Table 18. Global Chitosan-based Hemostatic Gauze Sales Market Share by Region (2021–2026)
Table 19. Global Chitosan-based Hemostatic Gauze Sales by Region (Units), 2027–2032
Table 20. Global Chitosan-based Hemostatic Gauze Sales Market Share by Region (2027–2032)
Table 21. Global Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2021–2026
Table 22. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2021–2026)
Table 23. Global Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2027–2032
Table 24. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2027–2032)
Table 25. North America Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026
Table 27. North America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032
Table 28. North America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026
Table 29. North America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026
Table 32. Europe Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032
Table 33. Europe Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Chitosan-based Hemostatic Gauze Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Chitosan-based Hemostatic Gauze Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Chitosan-based Hemostatic Gauze Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026
Table 42. Latin America Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032
Table 43. Latin America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Chitosan-based Hemostatic Gauze Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue by Country (US$ Million), 2027–2032
Table 50. Global Chitosan-based Hemostatic Gauze Sales (Units) by Type (2021–2026)
Table 51. Global Chitosan-based Hemostatic Gauze Sales (Units) by Type (2027–2032)
Table 52. Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2021–2026)
Table 53. Global Chitosan-based Hemostatic Gauze Sales Market Share by Type (2027–2032)
Table 54. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2021–2026)
Table 57. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Type (2027–2032)
Table 58. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Type (2021–2026)
Table 59. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Type (2027–2032)
Table 60. Global Chitosan-based Hemostatic Gauze Sales (Units) by Application (2021–2026)
Table 61. Global Chitosan-based Hemostatic Gauze Sales (Units) by Application (2027–2032)
Table 62. Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2021–2026)
Table 63. Global Chitosan-based Hemostatic Gauze Sales Market Share by Application (2027–2032)
Table 64. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Chitosan-based Hemostatic Gauze Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2021–2026)
Table 67. Global Chitosan-based Hemostatic Gauze Revenue Market Share by Application (2027–2032)
Table 68. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Application (2021–2026)
Table 69. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Application (2027–2032)
Table 70. Anscare Company Information
Table 71. Anscare Description and Business Overview
Table 72. Anscare Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Anscare Chitosan-based Hemostatic Gauze Product
Table 74. Anscare Recent Developments/Updates
Table 75. Tricol Biomedical Company Information
Table 76. Tricol Biomedical Description and Business Overview
Table 77. Tricol Biomedical Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Tricol Biomedical Chitosan-based Hemostatic Gauze Product
Table 79. Tricol Biomedical Recent Developments/Updates
Table 80. Advamedica Company Information
Table 81. Advamedica Description and Business Overview
Table 82. Advamedica Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Advamedica Chitosan-based Hemostatic Gauze Product
Table 84. Advamedica Recent Developments/Updates
Table 85. Hemoflex Company Information
Table 86. Hemoflex Description and Business Overview
Table 87. Hemoflex Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hemoflex Chitosan-based Hemostatic Gauze Product
Table 89. Hemoflex Recent Developments/Updates
Table 90. Mermaid Medical Company Information
Table 91. Mermaid Medical Description and Business Overview
Table 92. Mermaid Medical Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Mermaid Medical Chitosan-based Hemostatic Gauze Product
Table 94. Mermaid Medical Recent Developments/Updates
Table 95. BioPharm Med Company Information
Table 96. BioPharm Med Description and Business Overview
Table 97. BioPharm Med Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. BioPharm Med Chitosan-based Hemostatic Gauze Product
Table 99. BioPharm Med Recent Developments/Updates
Table 100. MedTrade Products Company Information
Table 101. MedTrade Products Description and Business Overview
Table 102. MedTrade Products Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. MedTrade Products Chitosan-based Hemostatic Gauze Product
Table 104. MedTrade Products Recent Developments/Updates
Table 105. Shijiazhuang Yishengtang Medical Product Company Information
Table 106. Shijiazhuang Yishengtang Medical Product Description and Business Overview
Table 107. Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Shijiazhuang Yishengtang Medical Product Chitosan-based Hemostatic Gauze Product
Table 109. Shijiazhuang Yishengtang Medical Product Recent Developments/Updates
Table 110. Biotemed Company Information
Table 111. Biotemed Description and Business Overview
Table 112. Biotemed Chitosan-based Hemostatic Gauze Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Biotemed Chitosan-based Hemostatic Gauze Product
Table 114. Biotemed Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Chitosan-based Hemostatic Gauze Distributors List
Table 118. Chitosan-based Hemostatic Gauze Customers List
Table 119. Chitosan-based Hemostatic Gauze Market Trends
Table 120. Chitosan-based Hemostatic Gauze Market Drivers
Table 121. Chitosan-based Hemostatic Gauze Market Challenges
Table 122. Chitosan-based Hemostatic Gauze Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chitosan-based Hemostatic Gauze
Figure 2. Global Chitosan-based Hemostatic Gauze Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Chitosan-based Hemostatic Gauze Market Share by Type: 2025 & 2032
Figure 4. Z-shaped Folded Hemostatic Gauze Product Picture
Figure 5. Non-folded Hemostatic Gauze Product Picture
Figure 6. Global Chitosan-based Hemostatic Gauze Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Chitosan-based Hemostatic Gauze Market Share by Application: 2025 & 2032
Figure 8. Surgery
Figure 9. First Aid
Figure 10. Global Chitosan-based Hemostatic Gauze Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Chitosan-based Hemostatic Gauze Market Size (US$ Million), 2021–2032
Figure 12. Global Chitosan-based Hemostatic Gauze Sales (Units), 2021–2032
Figure 13. Global Chitosan-based Hemostatic Gauze Average Price (US$/Unit), 2021–2032
Figure 14. Chitosan-based Hemostatic Gauze Report Years Considered
Figure 15. Chitosan-based Hemostatic Gauze Sales Share by Manufacturers in 2025
Figure 16. Global Chitosan-based Hemostatic Gauze Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Chitosan-based Hemostatic Gauze Players: Market Share by Revenue in Chitosan-based Hemostatic Gauze in 2025
Figure 18. Chitosan-based Hemostatic Gauze Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Chitosan-based Hemostatic Gauze Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)
Figure 21. North America Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)
Figure 22. United States Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)
Figure 25. Europe Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)
Figure 26. Germany Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Chitosan-based Hemostatic Gauze Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Chitosan-based Hemostatic Gauze Revenue Market Share by Region (2021–2032)
Figure 33. China Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)
Figure 41. Latin America Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Chitosan-based Hemostatic Gauze Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Chitosan-based Hemostatic Gauze Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Chitosan-based Hemostatic Gauze Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Chitosan-based Hemostatic Gauze by Type (2021–2032)
Figure 52. Global Revenue Market Share of Chitosan-based Hemostatic Gauze by Type (2021–2032)
Figure 53. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Chitosan-based Hemostatic Gauze by Application (2021–2032)
Figure 55. Global Revenue Market Share of Chitosan-based Hemostatic Gauze by Application (2021–2032)
Figure 56. Global Chitosan-based Hemostatic Gauze Price (US$/Unit) by Application (2021–2032)
Figure 57. Chitosan-based Hemostatic Gauze Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Chitosan-based Hemostatic Gauze market?
The top companies in the global Chitosan-based Hemostatic Gauze market are Anscare、Tricol Biomedical、Advamedica.
Related Reports
Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 147
USD 4900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chitosan-based Hemostatic Gauze market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
Chitosan-based Hemostatic Gauze- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 107
USD 3950.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 133
USD 4900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chitosan-based Hemostatic Gauze market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Chitosan-based Hemostatic Gauze - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 92
USD 3950.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2025
The global market for Chitosan-based Hemostatic Gauze was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 84
USD 2900.00
(Single User License)
Global and United States Chitosan-based Hemostatic Gauze Market Report & Forecast 2024-2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published Date: 2024-10-17
Pages: 105
USD 4350.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Research Report 2024
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published Date: 2024-10-17
Pages: 78
USD 2900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Insights, Forecast to 2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published Date: 2024-10-17
Pages: 127
USD 4900.00
(Single User License)
Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 147
USD 4900.00 (Single User License)Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chitosan-based Hemostatic Gauze market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
USD 4250.00 (Single User License)Chitosan-based Hemostatic Gauze- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 107
USD 3950.00 (Single User License)Global Chitosan-based Hemostatic Gauze Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chitosan-based Hemostatic Gauze market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 133
USD 4900.00 (Single User License)Global Chitosan-based Hemostatic Gauze Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chitosan-based Hemostatic Gauze market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)Chitosan-based Hemostatic Gauze - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chitosan-based Hemostatic Gauze was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 92
USD 3950.00 (Single User License)Global Chitosan-based Hemostatic Gauze Market Research Report 2025
The global market for Chitosan-based Hemostatic Gauze was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 84
USD 2900.00 (Single User License)Global and United States Chitosan-based Hemostatic Gauze Market Report & Forecast 2024-2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published: 2024-10-17
Pages: 105
USD 4350.00 (Single User License)Global Chitosan-based Hemostatic Gauze Market Research Report 2024
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published: 2024-10-17
Pages: 78
USD 2900.00 (Single User License)Global Chitosan-based Hemostatic Gauze Market Insights, Forecast to 2030
Chitosan hemostatic gauze is a medical gauze made of natural polymer chitosan, which has excellent hemostatic properties and biocompatibility. Chitosan is a substance extracted from the shells of crustaceans that can promote platelet aggregation and blood clot formation, thereby accelerating the hemostasis process. This gauze is often used for wound treatment in trauma, surgery and emergency situations. It can not only stop bleeding quickly, but also reduce the risk of infection and promote wound healing.
Published: 2024-10-17
Pages: 127
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now